Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

Magnetosome-like structure with high tumour tissue penetration efficiency constructed

Magnetosome-like structure with high tumour tissue penetration efficiency constructed

Sugar molecules as a target in cancer therapy

Sugar molecules as a target in cancer therapy

Researchers find treatment options for patients whose blood cancer relapses after CAR-T

Researchers find treatment options for patients whose blood cancer relapses after CAR-T

Study finds that patients with cancer and a suppressed immune system are at high risk for severe COVID if treated with systemic drug therapies

Study finds that patients with cancer and a suppressed immune system are at high risk for severe COVID if treated...

NCCN working with Medlive to advance high-quality cancer care in China and worldwide

NCCN working with Medlive to advance high-quality cancer care in China and worldwide

Zanubrutinib receives European commission approval for the treatment of adults with marginal zone lymphoma

Zanubrutinib receives European commission approval for the treatment of adults with marginal zone lymphoma

How ‘chameleon cancers’ can change their colors to survive treatment

How ‘chameleon cancers’ can change their colors to survive treatment

Advanced nanoparticles provide new weapon to fight difficult cancers

Advanced nanoparticles provide new weapon to fight difficult cancers

Scientists pinpoint druggable target in aggressive breast cancer

Scientists pinpoint druggable target in aggressive breast cancer

$FDA approves teclistamab-cqyv for relapsed or refractory multiple myeloma$

FDA approves teclistamab-cqyv for relapsed or refractory multiple myeloma

More from ecancer